+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glucuronolactone Market by Application, Form, Distribution Channel, End-User, Source - Global Forecast to 2030- Product Image
Glucuronolactone Market by Application, Form, Distribution Channel, End-User, Source - Global Forecast to 2030- Product Image
Sale

Glucuronolactone Market by Application, Form, Distribution Channel, End-User, Source - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716350
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glucuronolactone Market grew from USD 418.99 million in 2024 to USD 445.67 million in 2025. It is expected to continue growing at a CAGR of 6.13%, reaching USD 598.81 million by 2030.

Unveiling the Critical Role of Glucuronolactone in Modern Industries

Glucuronolactone has emerged as a pivotal compound across an expanding array of health and wellness sectors. Initially recognized for its role in detoxification pathways within the human body, this molecule now underpins innovative formulations in energy beverages, dietary supplements, and cosmetic products. Its ability to support metabolic clearance and bolster antioxidant defenses has attracted the attention of formulators seeking to enhance cognitive focus and physical recovery in end users.

As the industry evolves, stakeholders from ingredient suppliers to brand owners are navigating a landscape marked by heightened consumer expectations and advancing scientific understanding. Decision makers require a concise yet comprehensive perspective on how glucuronolactone is being leveraged, the factors shaping its adoption, and the strategic imperatives for maintaining a competitive edge. This executive summary delivers that perspective, laying the groundwork for informed strategy development and investment prioritization.

Shifts Redefining the Glucuronolactone Landscape

A confluence of regulatory scrutiny, technological innovation, and shifting consumer preferences is redefining the boundaries of the glucuronolactone market. Stricter quality standards imposed by health authorities are driving greater transparency throughout the supply chain, while advances in extraction and synthesis methods are enhancing purity and reducing production costs. These developments have unlocked new possibilities for formulators to integrate this compound into next-generation performance supplements and wellness solutions.

Concurrently, consumers are gravitating toward products that promise clear functional benefits, sustainability credentials, and validated ingredient performance. This shift has spurred collaboration between ingredient manufacturers and brand owners to co-create proprietary formulations, backed by clinical research and traceability assurances. As these transformative trends gain momentum, organizations that anticipate regulatory changes and embrace open innovation will be best positioned to capture market share and foster lasting customer loyalty.

Tariff Dynamics Shaping US Glucuronolactone Market

The introduction of new tariff measures in 2025 has altered the cost calculus for importing glucuronolactone into the United States, compelling manufacturers and distributors to reassess sourcing strategies. Historically reliant on imports from regions with established production capacities, companies are now facing increased landed costs that can erode margins and delay time to market. In response, some stakeholders are accelerating plans to secure domestic or near-shore supply agreements to mitigate exposure to external duties.

This reorientation toward local sourcing is also influencing contractual structures and inventory management practices. Organizations are leveraging multi-tier supplier networks to balance cost efficiency with supply chain resilience. While the short-term impact may manifest as incremental price adjustments for end users, the long-term implication is a more diversified and stable supply ecosystem that can adapt more swiftly to policy shifts and global trade disruptions.

Unlocking Segment-Specific Opportunities Across Applications and Channels

Application analysis reveals a broad spectrum of end-use categories that extend from personal care formulations to therapeutic products. Cosmetic developers harness glucuronolactone’s antioxidant attributes in skin-care serums and topical treatments, whereas dietary supplement manufacturers tailor offerings into capsule, powder, and tablet formats to address performance, wellness, and recovery needs. Beverage innovators infuse energy drinks and functional refreshments with this compound to enhance mental alertness and oxidative stress resistance, while food and beverage processors explore enriched formulations to deliver added value through everyday consumption.

Form selection further underscores market versatility, with capsule, liquid, powder, and tablet presentations enabling precise dosing and consumer convenience. Distribution channels encompass traditional retail environments such as convenience stores, pharmacies, and hypermarkets, alongside digital storefronts ranging from direct-to-consumer websites to large-scale e-commerce platforms. This omni-channel approach ensures broad accessibility and aligns with evolving purchasing behaviors. End-user segmentation categorizes demand among adults seeking general health support, athletes targeting performance optimization, and seniors focusing on age-related vitality. Meanwhile, the dichotomy between natural and synthetic sources influences both regulatory pathways and consumer perceptions, with natural-origin glucuronolactone often commanding premium positioning based on purity and traceability narratives.

Regional Momentum Driving Global Glucuronolactone Adoption

In the Americas, strong consumer awareness of functional ingredients has fostered rapid integration of glucuronolactone into sports nutrition and dietary supplement portfolios. Brand differentiation hinges on transparent sourcing and substantiated health claims, as regulatory agencies maintain robust oversight of label accuracy. In Europe, Middle East & Africa, a combination of stringent safety standards and growing demand for performance-enhancing products is catalyzing strategic alliances between ingredient innovators and local distributors. These partnerships aim to navigate complex regulatory frameworks while accelerating market entry.

Across Asia-Pacific, population demographics and rising disposable incomes are propelling demand for both traditional health supplements and modern functional beverages that feature glucuronolactone. Regional manufacturers are investing in production capacity and R&D collaborations to tailor formulations that resonate with local taste profiles and consumption rituals. This dynamic interplay between regulatory environments, consumer aspirations, and manufacturing capabilities is shaping differentiated regional strategies that collectively drive global growth.

Competitive Pulse Leading Players in the Glucuronolactone Arena

Leading ingredient suppliers have been consolidating their market positions through capacity expansions and quality certification initiatives, aimed at securing strategic raw material sources and demonstrating compliance with the highest safety standards. End-use brands are pursuing proprietary blends that combine glucuronolactone with complementary actives such as B vitamins and adaptogenic extracts, thereby creating unique value propositions in crowded market segments. Cross-industry alliances are also on the rise, as formulators in cosmetics and pharmaceuticals explore co-development agreements to tap into shared research capabilities and distribution networks.

In parallel, emerging players are differentiating themselves through niche offerings, including premium natural-source glucuronolactone backed by traceability audits and eco-friendly extraction processes. This diversification of competitive approaches-from scale-driven cost leadership to specialty branding-underscores the multifaceted nature of competition within the glucuronolactone ecosystem.

Strategic Imperatives for Industry Leaders

Organizations should consider establishing dual-sourcing strategies that combine domestic and international suppliers, thereby hedging against tariff volatility and ensuring continuity of supply. Prioritizing investment in R&D partnerships will accelerate the development of proprietary formulations that leverage glucuronolactone’s unique biochemical profile, reinforcing brand differentiation. It is equally critical to engage with regulatory bodies early in the product development cycle, securing clarity on permissible health claims and compliance requirements to avoid market entry delays.

Digital transformation initiatives can further augment distribution efficiencies, enabling real-time inventory management and personalized consumer outreach. Companies that harness data analytics to track purchasing patterns and end-user feedback will be better equipped to iterate rapidly on product iterations. Finally, cultivating transparent communication around sourcing ethics and quality standards will resonate with discerning consumers and build long-term trust.

Rigorous Research Framework Underpinning Our Analysis

This analysis draws upon a rigorous methodology that integrates comprehensive secondary research with targeted primary engagement. A detailed review of regulatory documents, academic literature, and industry publications provided foundational context on compound properties, manufacturing processes, and market trends. These insights were augmented by in-depth interviews with key stakeholders, including ingredient producers, brand executives, and distribution partners, to capture current practices and strategic priorities.

To ensure the robustness of findings, data points were triangulated across multiple sources and subjected to consistency checks. Quality assurance protocols, including peer reviews by subject-matter experts, were employed throughout the research lifecycle. This multi-tiered approach delivers a high degree of confidence in the integrity and relevance of the insights presented.

Synthesis of Insights on Glucuronolactone Market Dynamics

The glucuronolactone market is characterized by dynamic interplays between regulatory evolution, consumer demand shifts, and competitive innovation. While tariff adjustments present short-term supply challenges, they also incentivize resilient sourcing strategies and regional diversification. Segmentation analysis underscores the necessity of tailored approaches across applications, formats, channels, and user groups, while regional perspectives reveal distinct growth drivers that inform localized roadmaps.

By synthesizing these dimensions, stakeholders gain a holistic view of the forces shaping the industry and the levers available to capture emerging opportunities. Adopting proactive measures-such as collaborative R&D, digital enablement, and transparent quality assurances-will position organizations to thrive amid ongoing market transformations.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cosmetics
    • Dietary Supplement
      • Capsule
      • Powder
      • Tablet
    • Energy Drink
    • Food And Beverage
    • Pharmaceuticals
  • Form
    • Capsule
    • Liquid
    • Powder
    • Tablet
  • Distribution Channel
    • Offline
      • Convenience Stores
      • Pharmacies
      • Supermarkets And Hypermarkets
    • Online
      • Direct To Consumer
      • E-Commerce Platforms
  • End-User
    • Adults
    • Athletes
    • Seniors
  • Source
    • Natural
    • Synthetic
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • BASF SE
  • Eastman Chemical Company
  • Merck KGaA
  • Mitsui Chemicals, Inc.
  • Nouryon Chemicals International B.V.
  • Jungbunzlauer Suisse AG
  • Cariflex Industries S.A.
  • Hubei Biocause Biotechnology Co., Ltd.
  • Shandong Luwei Biochemical Co., Ltd.
  • Hangzhou Zhuwei Biosciences Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glucuronolactone Market, by Application
8.1. Introduction
8.2. Cosmetics
8.3. Dietary Supplement
8.3.1. Capsule
8.3.2. Powder
8.3.3. Tablet
8.4. Energy Drink
8.5. Food and Beverage
8.6. Pharmaceuticals
9. Glucuronolactone Market, by Form
9.1. Introduction
9.2. Capsule
9.3. Liquid
9.4. Powder
9.5. Tablet
10. Glucuronolactone Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.2.1. Convenience Stores
10.2.2. Pharmacies
10.2.3. Supermarkets and Hypermarkets
10.3. Online
10.3.1. Direct to Consumer
10.3.2. E-Commerce Platforms
11. Glucuronolactone Market, by End-User
11.1. Introduction
11.2. Adults
11.3. Athletes
11.4. Seniors
12. Glucuronolactone Market, by Source
12.1. Introduction
12.2. Natural
12.3. Synthetic
13. Americas Glucuronolactone Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Glucuronolactone Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Glucuronolactone Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. BASF SE
16.3.2. Eastman Chemical Company
16.3.3. Merck KGaA
16.3.4. Mitsui Chemicals, Inc.
16.3.5. Nouryon Chemicals International B.V.
16.3.6. Jungbunzlauer Suisse AG
16.3.7. Cariflex Industries S.A.
16.3.8. Hubei Biocause Biotechnology Co., Ltd.
16.3.9. Shandong Luwei Biochemical Co., Ltd.
16.3.10. Hangzhou Zhuwei Biosciences Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GLUCURONOLACTONE MARKET MULTI-CURRENCY
FIGURE 2. GLUCURONOLACTONE MARKET MULTI-LANGUAGE
FIGURE 3. GLUCURONOLACTONE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GLUCURONOLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLUCURONOLACTONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GLUCURONOLACTONE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GLUCURONOLACTONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLUCURONOLACTONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ENERGY DRINK, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY ATHLETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GLUCURONOLACTONE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES GLUCURONOLACTONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. CANADA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 58. CANADA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 59. CANADA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. CANADA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 61. CANADA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 62. CANADA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. MEXICO GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. GERMANY GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 107. GERMANY GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 108. GERMANY GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. GERMANY GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 110. GERMANY GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. GERMANY GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. FRANCE GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FRANCE GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 115. FRANCE GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 116. FRANCE GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. ITALY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 131. ITALY GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. ITALY GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. ITALY GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 134. ITALY GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 135. ITALY GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. ITALY GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. SPAIN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SPAIN GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 139. SPAIN GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 140. SPAIN GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. SPAIN GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 142. SPAIN GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 143. SPAIN GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. SPAIN GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 171. DENMARK GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 172. DENMARK GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. DENMARK GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 174. DENMARK GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 175. DENMARK GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. DENMARK GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. QATAR GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 187. QATAR GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 188. QATAR GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. QATAR GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 190. QATAR GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 191. QATAR GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. QATAR GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 195. FINLAND GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 196. FINLAND GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. FINLAND GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 198. FINLAND GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. FINLAND GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. EGYPT GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 219. EGYPT GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 220. EGYPT GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. EGYPT GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 222. EGYPT GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 223. EGYPT GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. EGYPT GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 227. TURKEY GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 228. TURKEY GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. TURKEY GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 230. TURKEY GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. TURKEY GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NORWAY GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 244. NORWAY GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. NORWAY GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. NORWAY GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 249. POLAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 251. POLAND GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 252. POLAND GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. POLAND GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 254. POLAND GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 255. POLAND GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. POLAND GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC GLUCURONOLACTONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 274. CHINA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. CHINA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 276. CHINA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 277. CHINA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. CHINA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 279. CHINA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 280. CHINA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. CHINA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 282. INDIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. INDIA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 284. INDIA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 285. INDIA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. INDIA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 287. INDIA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 288. INDIA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. INDIA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. JAPAN GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 292. JAPAN GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 293. JAPAN GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. JAPAN GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 295. JAPAN GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 296. JAPAN GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. JAPAN GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. THAILAND GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 324. THAILAND GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 325. THAILAND GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. THAILAND GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 327. THAILAND GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 328. THAILAND GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 329. THAILAND GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 353. SINGAPORE GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 359. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 360. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 361. VIETNAM GLUCURONOLACTONE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN GLUCURONOLACTONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN GLUCURONOLACTONE MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 364. TAIWAN GLUCURONOLACTONE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 365. TAIWAN GLUCURONOLACTONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 366. TAIWAN GLUCURONOLACTONE MAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Glucuronolactone market report include:
  • BASF SE
  • Eastman Chemical Company
  • Merck KGaA
  • Mitsui Chemicals, Inc.
  • Nouryon Chemicals International B.V.
  • Jungbunzlauer Suisse AG
  • Cariflex Industries S.A.
  • Hubei Biocause Biotechnology Co., Ltd.
  • Shandong Luwei Biochemical Co., Ltd.
  • Hangzhou Zhuwei Biosciences Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 445.67 Million
Forecasted Market Value ( USD ) by 2030 $ 598.81 Million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Glucuronolactone - Global Strategic Business Report - Product Image

Glucuronolactone - Global Strategic Business Report

  • Report
  • 384 Pages
  • Global
From
2025 Glucuronolactone Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Glucuronolactone Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 148 Pages
  • Global
From
D-Glucuronolactone (CAS 32449-92-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

D-Glucuronolactone (CAS 32449-92-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Thiamine Market by Application, Form, Source, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Thiamine Market by Application, Form, Source, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Dietary Supplements Market by Product Type, Formulation, Packaging Type, Application, End User, Distribution Channels - Global Forecast to 2030 - Product Image

Dietary Supplements Market by Product Type, Formulation, Packaging Type, Application, End User, Distribution Channels - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From

About the Glucuronolactone Market

Glucuronolactone is a naturally occurring compound found in the human body and is a component of many dietary supplements. It is a type of sugar molecule that is used to help the body metabolize and eliminate toxins. It is also used to help support healthy liver function and is believed to have antioxidant properties. Glucuronolactone is often found in energy drinks and other dietary supplements, as it is believed to help improve mental alertness and physical performance. It is also used in some sports nutrition products to help athletes recover from strenuous exercise. Glucuronolactone is a popular ingredient in many vitamins and dietary supplements, as it is believed to have a range of health benefits. It is often used in combination with other ingredients, such as B vitamins, to help support overall health and wellness. It is also used in some weight loss supplements, as it is believed to help support healthy metabolism and energy levels. Some companies that produce products containing glucuronolactone include NOW Foods, Nature's Way, and Jarrow Formulas. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.